Abstract

Objective:To determine the susceptibility pattern and frequency of isolation of multidrug, pre-extensively drug and extensively drug resistant TB in a tertiary care hospital in Karachi, Pakistan.Method:A cross-sectional study was designed. Samples received in the lab were processed for growth and sensitivity testing of Mycobacterium tuberculosis. Isolation of MTB was done on Mycobacteria growth indicator tube (MGIT) followed by identification using MPT64. Samples were than evaluated for drug sensitivity against first and second-line antimycobacterial drugs. Statistical analysis was performed using SPSS version 24.0.Results:Of the 20014 samples received, 23.1% were identified as Mycobacterium tuberculosis. Drug sensitivity testing was performed on 95.9% isolates. Fifty-two percent samples were from males and 48% female patients. The study found statistically non-significant relationship between gender and likelihood of disease with drug-resistant (DR)-MTB organisms. The rate of isolation of MDR-TB was highest (43%) among ages 25-55 years and previously treated patients compared to newly diagnosed patients (62% vs 36%). Among MTB positive samples, 91.5% were pulmonary while 8.5% were extrapulmonary samples. Extrapulmonary samples were more likely to be sensitive to antimycobacterial drugs. The highest resistance was observed against Isoniazid (pulmonary=58%; extrapulmonary=12.7%), Rifampicin (pulmonary=58.7%; extrapulmonary=8.2%), and Levofloxacin (pulmonary=29.2%; extrapulmonary=20%).Conclusion:A considerable number of drug resistant tuberculosis cases were identified in the present study. It is essential to develop further strategies to reduce the spread of this disease.

Highlights

  • Mycobacterium tuberculosis (MTB) is the 9th leading cause of death with annually 10 million new cases and 1.7 million deaths worldwide.[1]

  • 30 high TB burden countries Pakistan has been ranked at fifth position according to WHO Report 2020.2 According to WHO Eastern Mediterranean Regional Office (EMRO) reports (2019), there were approximately 265 incidences of TB per 100,000 population in Pakistan

  • Out of 4652 positive samples, drug susceptibility testing (DST) was performed on 4463 (95.9%) isolates identified as MTB, 115 (2.4%) were identified as MOTT (Mycobacterium other than MTB), while 74 (1.5%) were MTB positive with contamination

Read more

Summary

Introduction

Mycobacterium tuberculosis (MTB) is the 9th leading cause of death with annually 10 million new cases and 1.7 million deaths worldwide.[1] Among. Correspondence: 30 high TB burden countries Pakistan has been ranked at fifth position according to WHO Report 2020.2 According to WHO Eastern Mediterranean Regional Office (EMRO) reports (2019), there were approximately 265 incidences of TB per 100,000 population in Pakistan. There were 15, 5537 (new and previously treated) cases of TB reported during 9 months in 2020 in Pakistan. TB is a curable and preventable disease, with 85% cure rate,[3] emergence of Multidrug resistance (MDR) strains worsens the situation. Pakistan ranks fourth among the 27 high MDR-TB burden countries.[4]. Pak J Med Sci January 2022 Vol 38 No 2 Special Issue www.pjms.org.pk 399

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call